A food allergy research and patient advocacy group has helped craft a newly introduced bill the group says could foster new therapies by encouraging government agencies such as FDA to collect more data on the patient experience and economic costs of living with food allergies. However, one consumer advocate says the bill, introduced Monday (April 8) by Rep. Doris Matsui (D-CA), is too vague about what data should be collected. Based on the recommendations made in a 2016 study by...